Salvianolic acid B targets mortalin and inhibits the migration and invasion of hepatocellular carcinoma via the RECK/STAT3 pathway
Open Access
- 7 December 2021
- journal article
- research article
- Published by Springer Nature in Cancer Cell International
- Vol. 21 (1) , 1-13
Abstract
Background: Tumor migration and invasion is a complex and diverse process that involves the epithelial–mesenchymal transition (EMT) of tumor cells and degradation of the extracellular matrix by matrix metalloproteases (MMPs). Mortalin is an important oncogene. It has been reported to play an important role in tumor migration and invasion through various signaling pathways, but the underlying mechanism is not fully understood. Methods: Here, we investigated the role of mortalin in the migration of the hepatocellular carcinoma (HCC) cell lines HepG2 and HCCLM3. Results: The overexpression of mortalin in HepG2 cells decreased the protein level of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and activated the phosphorylation and acetylation of STAT3, thereby up-regulating matrix metalloproteinase 9 (MMP9) and promoting cell migration and invasion. In contrast, in HCCLM3 cells, mortalin knockdown increased the expression of RECK, inhibited the STAT3 pathway and the activity of MMP9, and inhibited cell migration and invasion. Furthermore, we found that salvianolic acid B, a caffeic acid phenethyl ester analog, specifically bound to mortalin and increased the degradation of mortalin proteasomes through ubiquitination, thereby up-regulating RECK, inhibiting STAT3, and finally inhibiting the migration and invasion of HCC cells. Conclusion: Our work suggested that mortalin is a potential therapeutic target for hepatocellular carcinoma.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (81573183, 81673205)
This publication has 29 references indexed in Scilit:
- Diverse matrix metalloproteinase functions regulate cancer amoeboid migrationNature Communications, 2014
- RECK controls breast cancer metastasis by modulating a convergent, STAT3-dependent neoangiogenic switchOncogene, 2014
- Molecular mechanisms of epithelial–mesenchymal transitionNature Reviews Molecular Cell Biology, 2014
- Mortalin is a prognostic factor of gastric cancer with normal p53 functionGastric Cancer, 2013
- Withanone binds to mortalin and abrogates mortalin–p53 complex: Computational and experimental evidenceThe International Journal of Biochemistry & Cell Biology, 2012
- More expressions of BDNF and TrkB in multiple hepatocellular carcinoma and anti-BDNF or K252a induced apoptosis, supressed invasion of HepG2 and HCCLM3 cellsJournal of Experimental & Clinical Cancer Research, 2011
- Extracellular Matrix Degradation and Remodeling in Development and DiseaseCold Spring Harbor Perspectives in Biology, 2011
- Association of Mortalin (HSPA9) with Liver Cancer Metastasis and Prediction for Early Tumor RecurrenceMolecular & Cellular Proteomics, 2008
- Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesisInternational Journal of Cancer, 2006
- The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and AngiogenesisCell, 2001